Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1371-1376

  Nansera, Denis ^a   Bajunirwe, F ^a   Elyanu, P ^b   Asiimwe, C ^b   Amanyire, G ^b   Graziano, F M ^c  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b Mulago Mbarara Teaching Hospitals Joint AIDS Programme   (Uganda)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Loss to follow up; Mortality; TB HIV

Indexed keywords

EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; SPUTUM EXAMINATION; THRUSH; TUBERCULOSIS; UGANDA; WASTING SYNDROME;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; TUBERCULOSIS; UGANDA;

EID: 84866439672     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0589     Document Type: Article

References (30)

1. Mukadi Y D, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001; 15: 143-152. (Pubitemid 32142288)
2. Connolly C, Reid A, Davies G, et al. Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS 1999; 13: 1543-1547. (Pubitemid 29396687)
3. Murray J, Sonnenberg P, Shearer S C, Godfrey-Faussett P. H uman immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999; 159: 733-740. (Pubitemid 29137767)
4. Lawn S D, Myer L, Orrell C, et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19: 2141-2148. (Pubitemid 41669003)
5. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021. (Pubitemid 36548927)
6. Adatu-Engwau F. Addressing the key challenges in tuberculosis and leprosy control in Uganda. Kampala, Uganda. Quarterly Newsletter on TB-HIV Activities, vol 3, issue II, April 2010.
7. Kigozi I M, Dobkin L M, Martin J N, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr 2009; 52: 280-289.
8. World Health Organization. Tuberculosis profile. Geneva, Switzerland: WHO, 2012. www.who.int/data Accessed June 2012.
9. World Health Organization. Global tuberculosis control - epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/publications/global-report/2009/pdf/full- report.pdf Accessed June 2012.
10. Gasana M, Vandebriel G, Kabanda G, et al. Integrating tuberculosis and HIV care in rural Rwanda. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S39-S43. (Pubitemid 351361917)
11. Geng E H, Glidden D V, Emenyonu N, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health 2010; 15: 63-69.
12. Ministry of Health, Uganda. Manual of the National Tuberculosis and Leprosy Programme. 2nd ed. Kampala, Uganda: MoH, 2010.
13. World Health Organization. Global database on body mass index. Geneva, Switzerland: WHO, 2006.
14. Khusun H, Yip R, Schultink W, Dillon D H. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr 1999; 129: 1669-1674. (Pubitemid 29406619)
15. World Health Organization/United Nations Children's Fund/ United Nations University. Indicators and strategies for iron deficiency and anaemia programmes. Report of a consultation, Geneva, 6-10 December 1993. Geneva, Switzerland: WHO/ UNICEF/UNU, 1995.
16. Expert Scientific Working Group. Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr 1985; 42: 1318-1330.
17. Lawn S D, Myer L, Harling G, Orrell C, Bekker L G, Wood R. Determinants of mortality and non-death losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006; 43: 770-776. (Pubitemid 44330743)
18. Lawn S D, Bekker L G, Middelkoop K, et al. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006; 42: 1040-1047.
19. Harries A D, Hargreaves N J, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-1523. (Pubitemid 32488877)
20. Harries A D, Boxshall M, Phiri S, et al. Providing HIV care for tuberculosis patients in sub-Saharan Africa. Int J Tuberc Lung Dis 2006; 10: 1306-1311. (Pubitemid 44924583)
21. Nansera D, Bajunirwe F, Kabakyenga J, Asiimwe P K J, M ayanja K H. Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. Afr Health Sci 2010; 10: 312-319.
22. Dong K, Thabethe Z, Hurtado R, et al. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. J Infectious Dis 2007; 196 (Suppl 3): S491-S496. (Pubitemid 351417243)
23. Dlodlo R A, Fujiwara P I, Enarson D A. Should tuberculosis treatment and control be addressed differently in HIVi nfected and -uninfected individuals? Eur Respir J 2005; 25: 751-757. (Pubitemid 40528771)
24. Rosen S, Fox Matthew P, Gill C J. Patient retention in anti-retroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4: e298.
25. Brinkhof M W, Pujades-Rodriguez M, Egger M, et al. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 2009; 4: e5790.
26. Dalal R P, MacPhail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008; 47: 101-107. (Pubitemid 351619376)
27. Zachariah R, Teck R, Ascurra O, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis 2005; 9: 238-247. (Pubitemid 40392937)
28. Haberer J E, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 2010; 14: 1340-1346.
29. Haberer J E, Kiwanuka J, Nansera D, Wilson I B, Bangsberg D R. Challenges in using mobile phones for collection of anti-retroviral therapy adherence data in a resource-limited setting. AIDS Behav 2010; 14: 1294-1301.
30. Fraser H S, Allen C, Bailey C, Douglas G, Shin S, Blaya J. Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resourcepoor areas. J Med Internet Res 2007; 9: e29.